Attending this event?
Back To Schedule
Wednesday, October 26 • 9:00am - 9:30am
Keynote: Assessing the Financial Value of Decentralized Clinical Trials

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

  • We developed a risk-adjusted discounted cash flow model (expected net present value) to measure the net financial benefit of decentralized clinical trials (DCTs)
  • Benchmark development data indicate that DCTs provide benefits from shorter clinical phase cycle times, reduced screen failure rates, and fewer substantial protocol amendments
  • This pilot study found a nearly five-fold return on investment (ROI) if DCT methods are applied to all phase II trials, a 13-fold ROI if applied to all phase III trials, and nearly a seven-fold ROI if applied to both phase II and phase III trials

avatar for Joseph DiMasi, PhD

Joseph DiMasi, PhD

Director of Economic Analysis, Tufts University

Wednesday October 26, 2022 9:00am - 9:30am EDT